{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Montgomery MK"],"funding":["Department of Health | National Health and Medical Research Council"],"pagination":["1259"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8913628"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["13(1)"],"pubmed_abstract":["Non-alcoholic steatohepatitis (NASH) and type 2 diabetes are closely linked, yet the pathophysiological mechanisms underpinning this bidirectional relationship remain unresolved. Using proteomic approaches, we interrogate hepatocyte protein secretion in two models of murine NASH to understand how liver-derived factors modulate lipid metabolism and insulin sensitivity in peripheral tissues. We reveal striking hepatokine remodelling that is associated with insulin resistance and maladaptive lipid metabolism, and identify arylsulfatase A (ARSA) as a hepatokine that is upregulated in NASH and type 2 diabetes. Mechanistically, hepatic ARSA reduces sulfatide content and increases lysophosphatidylcholine (LPC) accumulation within lipid rafts and suppresses LPC secretion from the liver, thereby lo"],"journal":["Nature communications"],"pubmed_title":["Deep proteomic profiling unveils arylsulfatase A as a non-alcoholic steatohepatitis inducible hepatokine and regulator of glycemic control."],"pmcid":["PMC8913628"],"funding_grant_id":["APP1098972","APP1077703","APP1143224","APP1162511"],"pubmed_authors":["Nie S","Ooi GJ","Huang C","Parker BL","Brown WA","Montgomery MK","De Nardo W","Miotto PM","Watt MJ","Bayliss J","Ryan A","Karimkhanloo H","Williamson NA","Schittenhelm RB","Don AS","Burton PR","Keenan SN"],"additional_accession":[]},"is_claimable":false,"name":"Deep proteomic profiling unveils arylsulfatase A as a non-alcoholic steatohepatitis inducible hepatokine and regulator of glycemic control.","description":"Non-alcoholic steatohepatitis (NASH) and type 2 diabetes are closely linked, yet the pathophysiological mechanisms underpinning this bidirectional relationship remain unresolved. Using proteomic approaches, we interrogate hepatocyte protein secretion in two models of murine NASH to understand how liver-derived factors modulate lipid metabolism and insulin sensitivity in peripheral tissues. We reveal striking hepatokine remodelling that is associated with insulin resistance and maladaptive lipid metabolism, and identify arylsulfatase A (ARSA) as a hepatokine that is upregulated in NASH and type 2 diabetes. Mechanistically, hepatic ARSA reduces sulfatide content and increases lysophosphatidylcholine (LPC) accumulation within lipid rafts and suppresses LPC secretion from the liver, thereby lo","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Mar","modification":"2025-04-22T18:21:54.783Z","creation":"2025-04-06T02:24:04.094Z"},"accession":"S-EPMC8913628","cross_references":{"pubmed":["35273160"],"doi":["10.1038/s41467-022-28889-2"]}}